Citation: | LI Xiangying, GANG Qiaojian, MU Liyuan, SHENG Yingda, HA Xiaoqin. Research progress of umbilical cord mesenchymal stem cell-derived exosomes in treatment of tumor[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 108-112, 118. DOI: 10.7619/jcmp.20222117 |
Umbilical cord mesenchymal stem cells are multidirectional stem cells from the umbilical cord that can inhibit tumor development through exosomes. Exosomes secreted by umbilical cord mesenchymal stem cells play an anti-tumor role by participating in immune response, inhibiting tumor cell proliferation, reducing angiogenesis and improving drug sensitivity. However, there are few studies on the application of exosomes secreted by umbilical cord mesenchymal stem cells in tumor therapy. The paper reviewed the mechanism of action and application prospect of these drugs in tumor therapy.
[1] |
SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72(1): 7-33. doi: 10.3322/caac.21708
|
[2] |
ANSARI M A, THIRUVENGADAM M, VENKIDASAMY B, et al. Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: current status and future perspectives[J]. Semin Cancer Biol, 2022.
|
[3] |
AHANI-NAHAYATI M, NIAZI V, MORADI A, et al. Umbilical cord mesenchymal stem/stromal cells potential to treat organ disorders; an emerging strategy[J]. Curr Stem Cell Res Ther, 2022, 17(2): 126-146. doi: 10.2174/1574888X16666210907164046
|
[4] |
GUO G, TAN Z, LIU Y, et al. The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer[J]. Stem Cell Res Ther, 2022, 13(1): 138. doi: 10.1186/s13287-022-02811-5
|
[5] |
HADE M D, SUIRE C N, SUO Z. Mesenchymal stem cell-derived exosomes: applications in regenerative medicine[J]. Cells, 2021, 10(8).
|
[6] |
YU D, LI Y, WANG M, et al. Exosomes as a new frontier of cancer liquid biopsy[J]. Mol Cancer, 2022, 21(1): 56. doi: 10.1186/s12943-022-01509-9
|
[7] |
KALLURI R, LEBLEU V S. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367(6478).
|
[8] |
杨丽娟, 张加苗, 张晶, 等. 外泌体在肿瘤中的作用及靶向治疗的研究进展[J]. 实用临床医药杂志, 2022, 26(8): 143-148. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202208027.htm
|
[9] |
LEE J R, PARK B W, KIM J, et al. Nanovesicles derived from iron oxide nanoparticles-incorporated mesenchymal stem cells for cardiac repair[J]. Sci Adv, 2020, 6(18): eaaz0952. doi: 10.1126/sciadv.aaz0952
|
[10] |
ZHANG F, GUO J, ZHANG Z, et al. Mesenchymal stem cell-derived exosome: a tumor regulator and carrier for targeted tumor therapy[J]. Cancer Letters, 2022, 526: 29-40. doi: 10.1016/j.canlet.2021.11.015
|
[11] |
ZHAO J, MA S, XU Y, et al. In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy[J]. Biomaterials, 2021, 268: 120542. doi: 10.1016/j.biomaterials.2020.120542
|
[12] |
YUAN L, LIU Y, QU Y, et al. Exosomes derived from microRNA-148b-3p-overexpressing human umbilical cord mesenchymal stem cells restrain breast cancer progression[J]. Front Oncol, 2019, 9: 1076. doi: 10.3389/fonc.2019.01076
|
[13] |
WANG S, LEI B, ZHANG E, et al. Targeted therapy for inflammatory diseases with mesenchymal stem cells and their derived exosomes: from basic to clinics[J]. International Journal of Nanomedicine 2022, 17: 1757-1781. doi: 10.2147/IJN.S355366
|
[14] |
REN G, ZHANG L, ZHAO X, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide[J]. Cell Stem Cell, 2008, 2(2): 141-150. doi: 10.1016/j.stem.2007.11.014
|
[15] |
ZHOU Y, DAY A, HAYKAL S, et al. Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway[J]. Cytotherapy, 2013, 15(10): 1195-1207. doi: 10.1016/j.jcyt.2013.05.009
|
[16] |
LI Y, ZHAO W, WANG Y, et al. Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment[J]. Journal of Nanobiotechnology, 2022, 20 (1): 208. doi: 10.1186/s12951-022-01382-0
|
[17] |
LI D, LIN F, LI G, et al. Exosomes derived from mesenchymal stem cells curbs the progression of clear cell renal cell carcinoma through T-cell immune response[J]. Cytotechnology, 2021, 73(4): 593-604. doi: 10.1007/s10616-021-00480-5
|
[18] |
JIA Y, DING X, ZHOU L, et al. Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1[J]. Oncogene, 2021, 40(2): 246-261. doi: 10.1038/s41388-020-01486-7
|
[19] |
QIU L, WANG J, CHEN M, et al. Exosomal microRNA-146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane via a LAMC2 mediated PI3K/Akt axis[J]. Int J Mol Med, 2020, 46(2): 609-620. doi: 10.3892/ijmm.2020.4634
|
[20] |
LI X, LIU L L, YAO J L, et al. Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibit Endometrial Cancer Cell Proliferation and Migration through Delivery of Exogenous miR-302a[J]. Stem Cells International, 2019, 2019: 8108576.
|
[21] |
HE Z, LI W, ZHENG T, et al. Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression[J]. Journal of experimental & clinical cancer research, 2020, 39(1): 140.
|
[22] |
TODOROVA D, SIMONCINI S, LACROIX R, et al. Extracellular vesicles in angiogenesis[J]. Circ Res, 2017, 120(10): 1658-1673. doi: 10.1161/CIRCRESAHA.117.309681
|
[23] |
PAKRAVAN K, BABASHAH S, SADEGHIZADEH M, et al. microRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells[J]. Cell Oncol, 2017, 40(5): 457-470. doi: 10.1007/s13402-017-0335-7
|
[24] |
LEE J K, PARK S R, JUNG B K, et al. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells[J]. PLoS One, 2013, 8(12): e84256. doi: 10.1371/journal.pone.0084256
|
[25] |
ROSENBERGER L, EZQUER M, LILLO-VERA F, et al. Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma[J]. Sci Rep, 2019, 9(1): 663. doi: 10.1038/s41598-018-36855-6
|
[26] |
LOU G, CHEN L, XIA C, et al. miR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway[J]. J Exp Clin Cancer Res, 2020, 39(1): 4. doi: 10.1186/s13046-019-1512-5
|
[27] |
刘强, 王玉杰, 李前进, 等. 过表达miR-145的脐带间充质干细胞外泌体改善肾细胞癌细胞786-0对舒尼替尼的药物敏感性[J]. 现代肿瘤医学, 2022, 30(6): 959-966. doi: 10.3969/j.issn.1672-4992.2022.06.003
|
[28] |
ZHAO L X, ZHANG K, SHEN B B, et al. Mesenchymal stem cell-derived exosomes for gastrointestinal cancer[J]. World J Gastrointest Oncol, 2021, 13(12): 1981-1996. doi: 10.4251/wjgo.v13.i12.1981
|
[29] |
LIM W, KIM H S. Exosomes as therapeutic vehicles for cancer[J]. Tissue Eng Regen Med, 2019, 16(3): 213-223. doi: 10.1007/s13770-019-00190-2
|
[30] |
TARASOV V V, SVISTUNOV A A, CHUBAREV V N, et al. Extracellular vesicles in cancer nanomedicine[J]. Semin Cancer Biol, 2021, 69: 212-225. doi: 10.1016/j.semcancer.2019.08.017
|
[31] |
PALAZZOLO S, MEMEO L, HADLA M, et al. Cancer extracellular vesicles: next-generation diagnostic and drug delivery nanotools[J]. Cancers: Basel, 2020, 12(11).
|
[32] |
AILUNO G, BALDASSARI S, LAI F, et al. Exosomes and extracellular vesicles as emerging theranostic platforms in cancer research[J]. Cells, 2020, 9(12).
|
[33] |
PIRISINU M, PHAM T C, ZHANG D X, et al. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: recent advances, current obstacles, and challenges for clinical translation[J]. Semin Cancer Biol, 2022, 80: 340-355. doi: 10.1016/j.semcancer.2020.08.007
|
[34] |
ZHU L, SUN H T, WANG S, et al. Isolation and characterization of exosomes for cancer research[J]. J Hematol Oncol, 2020, 13(1): 152. doi: 10.1186/s13045-020-00987-y
|
[35] |
ZHOU J, TAN X, TAN Y, et al. Mesenchymal stem cell derived exosomes in cancer progression, metastasis and drug delivery: a comprehensive review[J]. J Cancer, 2018, 9(17): 3129-3137. doi: 10.7150/jca.25376
|
[36] |
WU Q, ZHOU L, LV D, et al. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression[J]. Journal of Hematology & Oncology, 2019, 12(1): 53.
|
[37] |
MELZER C, REHN V, YANG Y, et al. Taxol-loaded MSC-derived exosomes provide a therapeutic vehicle to target metastatic breast cancer and other carcinoma cells[J]. Cancers, 2019, 11(6).
|
[38] |
SHAO J, ZARO J, SHEN Y. Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate[J]. Int J Nanomedicine, 2020, 15: 9355-9371. doi: 10.2147/IJN.S281890
|
[39] |
SUN Z, ZHANG J, LI J, et al. Roles of mesenchymal stem cell-derived exosomes in cancer development and targeted therapy[J]. Stem Cells Int, 2021, 2021: 9962194.
|
[40] |
WENG Z, ZHANG B, WU C, et al. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer[J]. J Hematol Oncol, 2021, 14(1): 136. doi: 10.1186/s13045-021-01141-y
|
[41] |
李洪强. 利用CRISPR/Cas9技术构建永生化脐带间充质干细胞系及其MYC-AS1转基因工程化外泌体抑癌功能初探[D]. 扬州: 扬州大学, 2021.
|
[42] |
XIE X, JI J, CHEN X, et al. Human umbilical cord mesenchymal stem cell-derived exosomes carrying hsa-miRNA-128-3p suppress pancreatic ductal cell carcinoma by inhibiting Galectin-3[J]. Clin Transl Oncol, 2022, 24(3): 517-531.
|
[43] |
XIE H, WANG J. microRNA-320a-containing exosomes from human umbilical cord mesenchymal stem cells curtail proliferation and metastasis in lung cancer by binding to SOX4[J]. Journal of Receptors and Signal Transduction, 2022, 42(3): 268-278. doi: 10.1080/10799893.2021.1918166
|
[44] |
LI T, WAN Y, SU Z, et al. Mesenchymal stem cell-derived exosomal microRNA-3940-5p inhibits colorectal cancer metastasis by targeting integrin α6[J]. Dig Dis Sci, 2021, 66(6): 1916-1927.
|
[45] |
MA H, WENG F, WANG L, et al. Extracellular vesicle-mediated delivery of miR-127-3p inhibits the proliferation and invasion of choriocarcinoma cells by targeting ITGA6[J]. Exp Cell Res, 2022, 414(2): 113098.
|